The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
Montecucco F, Di Marzo V, da Silva RF, Vuilleumier N, Capettini L, Lenglet S, Pagano S, Piscitelli F, Quintao S, Bertolotto M, Pelli G, Galan K, Pilet L, Kuzmanovic K, Burger F, Pane B, Spinella G, Braunersreuther V, Gayet-Ageron A, Pende A, Viviani GL, Palombo D, Dallegri F, Roux-Lombard P, Santos RA, Stergiopulos N, Steffens S, Mach F.
Montecucco F, et al. Among authors: vuilleumier n.
Eur Heart J. 2012 Apr;33(7):846-56. doi: 10.1093/eurheartj/ehr449. Epub 2011 Nov 22.
Eur Heart J. 2012.
PMID: 22112961
Free PMC article.